These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36601501)

  • 1. Cost benefit analysis of clinical pharmacist interventions in medical intensive care unit in Palestine medical complex: Prospective interventional study.
    Houso A; Hamdan M; Falana H
    Saudi Pharm J; 2022 Dec; 30(12):1718-1724. PubMed ID: 36601501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
    Muñoz-Pichuante D; Villa-Zapata L
    J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of pharmacist's interventions on cost of drug therapy in intensive care unit.
    Saokaew S; Maphanta S; Thangsomboon P
    Pharm Pract (Granada); 2009 Apr; 7(2):81-7. PubMed ID: 25152782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cost avoidance study of critical care pharmacists' interventions in a tertiary institution in Singapore.
    Chan LEJ; Soong JL; Lie SA
    Am J Health Syst Pharm; 2023 Feb; 80(5):267-283. PubMed ID: 36371740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-benefit analysis of clinical pharmacist intervention in preventing adverse drug events in the general chronic diseases outpatients.
    Al-Qudah RA; Al-Badriyeh D; Al-Ali FM; Altawalbeh SM; Basheti IA
    J Eval Clin Pract; 2020 Feb; 26(1):115-124. PubMed ID: 31234234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar.
    Abushanab D; Atchan M; Elajez R; Elshafei M; Abdelbari A; Al Hail M; Abdulrouf PV; El-Kassem W; Ademi Z; Fadul A; Abdalla E; Diab MI; Al-Badriyeh D
    PLoS One; 2023; 18(6):e0286419. PubMed ID: 37262042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, Economic, and Organizational Impact of the Clinical Pharmacist in an Orthopedic and Trauma Surgery Department.
    Renaudin P; Coste A; Audurier Y; Berbis J; Canovas F; Jalabert A; Castet-Nicolas A; Mercier G; Villiet M; Dagneaux L; Breuker C
    J Patient Saf; 2021 Dec; 17(8):e1507-e1513. PubMed ID: 30365407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Translated article] Implementation of the standardized process of drug therapy evaluation in inpatients and outpatients.
    González A; Gutiérrez W; Fuenzalida T; Lizana F; Gutiérrez M; Severino N
    Farm Hosp; 2023; 47(6):T254-T260. PubMed ID: 37735005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacists' interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis.
    Yakti O; Al-Badriyeh D; Rijims M; Abdelaal M; Alsoukhni O; Al Hail M; Abdulrouf PV; El-Kassem W; Abounahia F; Kaddoura R; Abushanab D
    J Pharm Policy Pract; 2024; 17(1):170-190. PubMed ID: 38236554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study.
    Klopotowska JE; Kuiper R; van Kan HJ; de Pont AC; Dijkgraaf MG; Lie-A-Huen L; Vroom MB; Smorenburg SM
    Crit Care; 2010; 14(5):R174. PubMed ID: 20920322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacist interventions in an intensive care unit reduces ICU mortality at a tertiary hospital in Dubai, United Arab Emirates.
    Ali Hussain Alsayed H; Saheb Sharif-Askari F; Saheb Sharif-Askari N; Halwani R
    Explor Res Clin Soc Pharm; 2024 Jun; 14():100431. PubMed ID: 38533449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
    Leape LL; Cullen DJ; Clapp MD; Burdick E; Demonaco HJ; Erickson JI; Bates DW
    JAMA; 1999 Jul; 282(3):267-70. PubMed ID: 10422996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and economic impact of pharmacist interventions in an ambulatory hematology-oncology department.
    de Grégori J; Pistre P; Boutet M; Porcher L; Devaux M; Pernot C; L Chrétien M; Rossi C; Manfredi S; Dalac S; Gueneau P; Boulin M
    J Oncol Pharm Pract; 2020 Jul; 26(5):1172-1179. PubMed ID: 32299314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expected net benefit of clinical pharmacy in intensive care medicine: a randomized interventional comparative trial with matched before-and-after groups.
    Claus BO; Robays H; Decruyenaere J; Annemans L
    J Eval Clin Pract; 2014 Dec; 20(6):1172-9. PubMed ID: 25470782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of the standardized process of Pharmacotherapeutic evaluation in inpatients and outpatients.
    González A; Gutiérrez W; Fuenzalida T; Lizana F; Gutiérrez M; Severino N
    Farm Hosp; 2023; 47(6):254-260. PubMed ID: 37198085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist interventions during patient rounds in two intensive care units: Clinical and financial impact.
    Bosma BE; van den Bemt PMLA; Melief PHGJ; van Bommel J; Tan SS; Hunfeld NGM
    Neth J Med; 2018 Apr; 76(3):115-124. PubMed ID: 29667584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital.
    Abushanab D; Gulied A; Hamad A; Abu-Tineh M; Abdul Rouf PV; Al Hail M; El-Kassem W; El Hajj MS; Al-Badriyeh D
    J Oncol Pharm Pract; 2023 Dec; 29(8):1935-1943. PubMed ID: 36946146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Descriptive Analysis of Acceptance by Prescribers and Economic Benefit of Pharmacist Recommended Interventions in a Critical Care Unit.
    Lee Y; Gettman L
    Innov Pharm; 2018; 9(2):1-20. PubMed ID: 34007688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section.
    Wang J; Dong M; Lu Y; Zhao X; Li X; Wen A
    Int J Clin Pharmacol Ther; 2015 Aug; 53(8):605-15. PubMed ID: 26104036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of clinical pharmacist interventions on the cost of drug therapy in intensive care units of a tertiary care teaching hospital.
    Lucca JM; Ramesh M; Narahari GM; Minaz N
    J Pharmacol Pharmacother; 2012 Jul; 3(3):242-7. PubMed ID: 23129959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.